Previous 10 | Next 10 |
2023-04-25 10:06:07 ET Gainers: Baudax Bio ( BXRX ) +48% . Petros Pharmaceuticals ( PTPI ) +48% . Morphic Holding ( MORF ) +22% . Arrowhead Pharmaceuticals ( ARWR ) +17% . Medpace Holdings ( MEDP ) +17% . Losers: Trac...
2023-04-24 17:11:41 ET Medpace Holdings ( NASDAQ: MEDP ) is up 23% in after-hours trading after boosting its 2023 full-year guidance for both revenue and EPS. For the former, the company is now projecting $1.75B to $1.81B. The previous forecast was $1.69B to $1.75B. Co...
2023-04-24 16:27:25 ET Medpace press release ( NASDAQ: MEDP ): Q1 GAAP EPS of $2.27 beats by $0.46 . Revenue of $434.07M (+31.2% Y/Y) beats by $31.24M . Net new business awards were $555.8 million in the first quarter of 2023, representing an increase of 31.4% ...
Revenue of $434.1 million in the first quarter of 2023 increased 31.2% from revenue of $330.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.6%. Net new business awards were $555.8 million in the first quarter of 2023, representing an increase o...
2023-04-11 03:21:30 ET Summary Strong financial growth in 2022, with healthy key performance metrics. Risks are contract cancellations, drug development unpredictability, and industry consolidation. DCF value at $215.94, potential 22.5% margin of safety with buybacks. ...
2023-04-01 08:44:59 ET Summary Cincinnati-based Medpace provides the biotechnology world with Phase 1-IV clinical development services using scientifically driven research. MEDP hit record Q4 2022 revenue of $394.1 million, indicating an increase of 27.7% (YoY), while full-year re...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2023 financial results after the market close on Monday, April 24, 2023. The Company will host a conference call the following morning, Tuesday, April 25, 2023, at 9:00 a.m. ET to...
2023-03-11 08:45:00 ET Whether you're growing from $200,000 to $1 million or hoping to take $20,000 to $100,000 over a period of 10 years, you'll need an average 17.5% annual return. While this would amount to market-beating returns, all three companies below have market capitalizations...
Medpace Holdings ( NASDAQ: MEDP ) has filed for an automatic shelf offering. The filing does not necessarily indicate that a sale has begun, or will occur in the future. The company noted that it will not receive any of the proceeds from the ~7.3M common shares being offered ...
Medpace Holdings, Inc. (MEDP) Q4 2022 Earnings Conference Call February 14, 2023, 09:00 AM ET Company Participants Lauren Morris - IR August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participants Sandy Draper - Guggenheim...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...